Eversept Partners’s Radius Health, Inc. RDUS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-502,587
Closed -$5.21M 89
2022
Q2
$5.21M Buy
502,587
+200,415
+66% +$1.49M 0.37% 45
2022
Q1
$2.67M Buy
+302,172
New +$2.29M 0.2% 56
2020
Q3
Sell
-220,110
Closed -$3M 74
2020
Q2
$3M Sell
220,110
-80,963
-27% -$1.11M 0.41% 37
2020
Q1
$3.91M Sell
301,073
-17,738
-6% -$316K 0.97% 24
2019
Q4
$6.43M Sell
318,811
-25,887
-8% -$629K 1.14% 25
2019
Q3
$8.88M Sell
344,698
-365,819
-51% -$8.96M 2.75% 8
2019
Q2
$17.3M Buy
710,517
+65,100
+10% +$1.42M 4.85% 7
2019
Q1
$12.9M Buy
645,417
+93,364
+17% +$1.7M 3.75% 8
2018
Q4
$9.1M Buy
552,053
+23,061
+4% +$388K 4.93% 6
2018
Q3
$9.42M Buy
528,992
+60,411
+13% +$1.37M 4.13% 8
2018
Q2
$13.8M Buy
468,581
+134,843
+40% +$4.26M 6.32% 4
2018
Q1
$12M Buy
333,738
+139,237
+72% +$5.03M 5.57% 4
2017
Q4
$6.18M Buy
+194,501
New +$6.1M 3.56% 10

Other funds holding RDUS

Eversept Partners's RDUS Position: Q3 2022 in Review

Eversept Partners sold out of Radius Health, Inc. (RDUS) in Q3 2022, closing a stake of 502,587 shares — an estimated $5.21M sold.

Eversept Partners first reported a position in RDUS in Q4 2017 and held it in 13 quarters. The position peaked at $17.3M in Q2 2019. 1 fund tracked by Wall St. Rank holds RDUS as of Q3 2022.

  • Eversept Partners reported no remaining Radius Health, Inc. position as of Q3 2022 after selling out during the quarter.
  • Eversept Partners sold 502,587 Radius Health, Inc. shares in Q3 2022, an estimated $5.21M.
  • Eversept Partners first reported a position in Radius Health, Inc. in Q4 2017 and held it in 13 quarters.
  • Eversept Partners's Radius Health, Inc. position peaked at $17.3M in Q2 2019.
  • 1 fund tracked by Wall St. Rank held Radius Health, Inc. as of Q3 2022.

Based on Eversept Partners's 13F filing for Q3 2022, filed 14 Nov 2022.